triamterene and hydrochlorothiazide
Generic: triamterene and hydrochlorothiazide
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
triamterene and hydrochlorothiazide
Generic Name
triamterene and hydrochlorothiazide
Labeler
preferred pharmaceuticals inc.
Dosage Form
TABLET
Routes
Active Ingredients
hydrochlorothiazide 50 mg/1, triamterene 75 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8624
Product ID
68788-8624_b7589c66-17d0-4b44-a504-d30fbc734808
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216211
Listing Expiration
2026-12-31
Marketing Start
2024-04-08
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888624
Hyphenated Format
68788-8624
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
triamterene and hydrochlorothiazide (source: ndc)
Generic Name
triamterene and hydrochlorothiazide (source: ndc)
Application Number
ANDA216211 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/1
- 75 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (68788-8624-1)
- 30 TABLET in 1 BOTTLE (68788-8624-3)
- 60 TABLET in 1 BOTTLE (68788-8624-6)
- 90 TABLET in 1 BOTTLE (68788-8624-9)
Packages (4)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b7589c66-17d0-4b44-a504-d30fbc734808", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["310818"], "spl_set_id": ["5fc69fbf-c2d2-41ef-99bb-62a76ef74db2"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8624-1)", "package_ndc": "68788-8624-1", "marketing_start_date": "20240408"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8624-3)", "package_ndc": "68788-8624-3", "marketing_start_date": "20240408"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8624-6)", "package_ndc": "68788-8624-6", "marketing_start_date": "20240408"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8624-9)", "package_ndc": "68788-8624-9", "marketing_start_date": "20240408"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "68788-8624_b7589c66-17d0-4b44-a504-d30fbc734808", "dosage_form": "TABLET", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "68788-8624", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "50 mg/1"}, {"name": "TRIAMTERENE", "strength": "75 mg/1"}], "application_number": "ANDA216211", "marketing_category": "ANDA", "marketing_start_date": "20240408", "listing_expiration_date": "20261231"}